Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis.
about
Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatmentSelective serotonin reuptake inhibitors for fibromyalgia syndromeSerotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndromeFibromyalgia: why such controversy?Central sensitivity syndromes: mounting pathophysiologic evidence to link fibromyalgia with other common chronic pain disordersThe science of fibromyalgiaBiology and therapy of fibromyalgia. New therapies in fibromyalgiaVitamin D in Fibromyalgia: A Causative or Confounding Biological Interplay?Exploring Genetic Susceptibility to FibromyalgiaThe association of sleep and pain: an update and a path forwardThe comorbidity of insomnia, chronic pain, and depression: dopamine as a putative mechanismMental Health Comorbidities in Pediatric Chronic Pain: A Narrative Review of Epidemiology, Models, Neurobiological Mechanisms and TreatmentCharacteristics of women who have had cosmetic breast implants that could be associated with increased suicide risk: a systematic review, proposing a suicide prevention modelL-tryptophan contaminant 'peak E' induces the release of IL-5 and IL-10 by peripheral blood mononuclear cells from patients with functional somatic syndromesThe NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenalineAltered functional magnetic resonance imaging responses to nonpainful sensory stimulation in fibromyalgia patients.Early life adversity as a risk factor for fibromyalgia in later life.Understanding fibromyalgia: lessons from the broader pain research community.Pain Catastrophizing is Not Associated with Spinal Nociceptive Processing in People with Chronic Widespread Pain.Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome.Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials.Fibromyalgia: presentation and management with a focus on pharmacological treatment.Chronic pain syndromes.Pathophysiology of fibromyalgia.A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia.Gene-to-gene interactions regulate endogenous pain modulation in fibromyalgia patients and healthy controls-antagonistic effects between opioid and serotonin-related genes.Sex differences in plasma prolactin response to tryptophan in chronic fatigue syndrome patients with and without comorbid fibromyalgiaRole and rationale for the use of milnacipran in the management of fibromyalgiaExamination and treatment of a patient with hypermobility syndrome.Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial.Is fibromyalgia a distinct clinical syndrome?Fibromyalgia and chronic fatigue syndrome: an update for athletic trainers.Milnacipran for the management of fibromyalgia syndrome.The fibromyalgia syndrome.Resting state connectivity correlates with drug and placebo response in fibromyalgia patientsIncreased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome.Vitamin D and Pain: Vitamin D and Its Role in the Aetiology and Maintenance of Chronic Pain States and Associated ComorbiditiesTherapy Insight: fibromyalgia--a different type of pain needing a different type of treatment.Serotonergic agents in the treatment of fibromyalgia syndrome.Antidepressants in the treatment of fibromyalgia.
P2860
Q21296574-5C822910-9487-4838-9C7B-2647ABFA6C56Q24187263-D6940353-1D41-4066-8268-A2354D07FF3DQ24201799-1886D801-BED7-45FF-B93D-AF38A883BE80Q24514803-5EFD1C75-8B10-4DB8-9F96-B91CA56AAE3CQ24604236-FFE0E839-5CE1-45D8-AF51-0142576F8F2AQ24609662-7AC17CC5-6C24-4930-A064-87783142FF83Q24684137-C3C8E051-117C-4A4B-AB92-E1F8744C20C2Q26748302-4206A1C5-8B15-4920-9E11-E06B8A97D6AEQ26797418-C5635B1A-A3A5-4B39-B176-979FAE8F00A3Q26852162-C4D24EE7-ED4B-42AD-A30C-32B04B6E3A80Q27024180-F505DAA3-D009-4DA6-8DB8-1D6DCDE0595FQ28069724-90DA11AF-E358-4221-9956-F0A79EB69E0FQ28082129-C2CFFDA2-0A88-444D-BD12-BFCAB82F208AQ28363652-E3213EAF-E291-468F-8CB1-F7526E737E11Q28592435-D9431FFB-CCED-4A1B-A7CE-3FF417D1376DQ30413565-E226A2E3-68BB-49EE-9AD0-EAC12F2BF755Q30472809-322667C1-3E6E-4092-95EA-9D722050B092Q30480264-CEA23A92-94D1-40E5-B4FD-4B9011F26FDDQ30490474-E1717DA3-5546-4B4E-B390-9DDDAA932A5CQ30613370-F812B588-91E6-456F-9A7B-B64C4BBD3646Q33469649-BBF16B02-CB8B-4B6A-AA32-317C13FC90B3Q33562399-56203820-1F0A-46CF-9643-56C22363D3F2Q33579110-AAEA2BD4-F598-4DC5-8EB1-6EBC4EB4E6A8Q33652567-BDC76B76-F58A-48D8-8C41-456986850EEEQ33734909-012FBA9D-F842-41D8-A1EB-E3D0645CDBB8Q33802439-B09ED54A-55A2-4380-BAF5-01BE41268773Q33874989-E3A174E7-7A99-4344-8608-FAB57FDA49FEQ33881505-92C7540B-E8BC-4316-BDC1-E68AC86CBA37Q33887582-AF8E47CD-2550-4CBC-BEF9-ED18FC878F20Q33992618-CD23442C-543E-493D-B80D-12003E512009Q34011229-AA53EB25-62C1-41DB-AB07-3A09F4C52874Q34240487-BEA6FB2D-75E1-427A-8C3E-B9F7786212C0Q34418392-33728658-74AE-4F82-BE4E-5396ABF5C9ACQ34419802-F46A4E47-C3D1-49AB-863E-A1E73E68BE8EQ34432234-8C129DB9-3480-4E01-968F-3F4B050B7D7EQ34440310-6A0071EF-2E6B-4E8A-BCAD-9E2C28AD117AQ34481412-D6B3D34C-02F2-4F72-BBCF-EBC9866CD67DQ34560547-0496B29F-F8B0-44DA-AC4C-D92CD8D4526CQ34579650-3F4E1FA1-8FBC-42D3-95F4-E19340411F13Q34607230-D3BC770F-71A5-4747-84D4-BD559A915AE1
P2860
Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis.
description
1992 nî lūn-bûn
@nan
1992 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Cerebrospinal fluid biogenic a ...... rome and rheumatoid arthritis.
@ast
Cerebrospinal fluid biogenic a ...... rome and rheumatoid arthritis.
@en
type
label
Cerebrospinal fluid biogenic a ...... rome and rheumatoid arthritis.
@ast
Cerebrospinal fluid biogenic a ...... rome and rheumatoid arthritis.
@en
prefLabel
Cerebrospinal fluid biogenic a ...... rome and rheumatoid arthritis.
@ast
Cerebrospinal fluid biogenic a ...... rome and rheumatoid arthritis.
@en
P2093
P356
P1476
Cerebrospinal fluid biogenic a ...... rome and rheumatoid arthritis.
@en
P2093
P2860
P304
P356
10.1002/ART.1780350509
P577
1992-05-01T00:00:00Z